tiprankstipranks
Conmed (CNMD)
NYSE:CNMD
US Market
CNMD
Conmed
RESEARCH TOOLSreports

Conmed (CNMD) Stock Forecast & Price Target

204 Followers
See the Price Targets and Ratings of:

CNMD Analyst Ratings

Hold
3Ratings
Hold
0 Buy
3 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Conmed
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CNMD Stock 12 Month Forecast

Average Price Target

$40.50
▼(-8.68% Downside)
Based on 3 Wall Street analysts offering 12 month price targets for Conmed in the last 3 months. The average price target is $40.50 with a high forecast of $42.00 and a low forecast of $39.00. The average price target represents a -8.68% change from the last price of $44.35.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"$38","55":"$55","72":"$72","46.5":"$46.5","63.5":"$63.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$42.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$40.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":39,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$39.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,46.5,55,63.5,72],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,45.49846153846154,45.206923076923076,44.91538461538462,44.62384615384615,44.332307692307694,44.04076923076923,43.74923076923077,43.457692307692305,43.16615384615385,42.87461538461538,42.58307692307692,42.291538461538465,{"y":42,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,45.38307692307692,44.97615384615384,44.56923076923077,44.16230769230769,43.755384615384614,43.348461538461535,42.941538461538464,42.534615384615385,42.12769230769231,41.72076923076923,41.31384615384616,40.90692307692308,{"y":40.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,45.26769230769231,44.745384615384616,44.223076923076924,43.70076923076923,43.17846153846154,42.65615384615384,42.13384615384615,41.61153846153846,41.08923076923077,40.566923076923075,40.04461538461538,39.52230769230769,{"y":39,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.004,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.766,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.969,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.865,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.092,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.154,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.16,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.21,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.79,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$42.00Average Price Target$40.50Lowest Price Target$39.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CNMD
Larry Biegelsen
Wells Fargo
Wells Fargo
$42
Hold
-5.30%
Downside
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Conmed (NYSE: CNMD), Alto Neuroscience, Inc. (NYSE: ANRO) and Pfizer (NYSE: PFE)
Piper Sandler Analyst forecast on CNMD
Matthew O'Brien
Piper Sandler
Piper Sandler
$55→$39
Hold
-12.06%
Downside
Downgraded
03/17/26
Maintaining a Neutral Stance Amid Persistent AirSeal Headwinds and Execution Challenges
Needham Analyst forecast on CNMD
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NASDAQ: NRIX), Sanofi (Other OTC: SNYNF) and Conmed (NYSE: CNMD)
Bank of America Securities Analyst forecast on CNMD
Travis Steed
Bank of America Securities
Bank of America Securities
$52
Hold
17.25%
Upside
Reiterated
12/08/25
Conmed's Strategic Exit from Gastroenterology: Hold Rating Amid Portfolio Optimization and Financial Adjustments
J.P. Morgan Analyst forecast on CNMD
Robbie Marcus
J.P. Morgan
J.P. Morgan
$58→$52
Hold
17.25%
Upside
Reiterated
11/06/25
Conmed price target lowered to $52 from $58 at JPMorganConmed price target lowered to $52 from $58 at JPMorgan
Jefferies Analyst forecast on CNMD
Unknown Analyst
Jefferies
Not Ranked
Jefferies
―
Hold
―
Reiterated
05/02/25
We maintain our Hold rating on CNMD.
Stifel Nicolaus Analyst forecast on CNMD
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$55
Hold
24.01%
Upside
Reiterated
05/01/25
Stifel Nicolaus Reaffirms Their Hold Rating on Conmed (CNMD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on CNMD
Larry Biegelsen
Wells Fargo
Wells Fargo
$42
Hold
-5.30%
Downside
Reiterated
03/17/26
Analysts Offer Insights on Healthcare Companies: Conmed (NYSE: CNMD), Alto Neuroscience, Inc. (NYSE: ANRO) and Pfizer (NYSE: PFE)
Piper Sandler Analyst forecast on CNMD
Matthew O'Brien
Piper Sandler
Piper Sandler
$55→$39
Hold
-12.06%
Downside
Downgraded
03/17/26
Maintaining a Neutral Stance Amid Persistent AirSeal Headwinds and Execution Challenges
Needham Analyst forecast on CNMD
Michael Matson
Needham
Needham
―
Hold
―
Reiterated
01/29/26
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NASDAQ: NRIX), Sanofi (Other OTC: SNYNF) and Conmed (NYSE: CNMD)
Bank of America Securities Analyst forecast on CNMD
Travis Steed
Bank of America Securities
Bank of America Securities
$52
Hold
17.25%
Upside
Reiterated
12/08/25
Conmed's Strategic Exit from Gastroenterology: Hold Rating Amid Portfolio Optimization and Financial Adjustments
J.P. Morgan Analyst forecast on CNMD
Robbie Marcus
J.P. Morgan
J.P. Morgan
$58→$52
Hold
17.25%
Upside
Reiterated
11/06/25
Conmed price target lowered to $52 from $58 at JPMorganConmed price target lowered to $52 from $58 at JPMorgan
Jefferies Analyst forecast on CNMD
Unknown Analyst
Jefferies
Not Ranked
Jefferies
―
Hold
―
Reiterated
05/02/25
We maintain our Hold rating on CNMD.
Stifel Nicolaus Analyst forecast on CNMD
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$55
Hold
24.01%
Upside
Reiterated
05/01/25
Stifel Nicolaus Reaffirms Their Hold Rating on Conmed (CNMD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CNMD Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
23
6
9
8
9
Hold
23
22
31
23
29
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
28
40
31
38
In the current month, CNMD has received 9 Buy Ratings, 29 Hold Ratings, and 0 Sell Ratings. CNMD average Analyst price target in the past 3 months is 40.50.
Each month's total comprises the sum of three months' worth of ratings.

CNMD Financial Forecast

CNMD Earnings Forecast

Next quarter’s earnings estimate for CNMD is $0.82 with a range of $0.81 to $0.83. The previous quarter’s EPS was $1.43. CNMD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CNMD has Performed in-line its overall industry.
Next quarter’s earnings estimate for CNMD is $0.82 with a range of $0.81 to $0.83. The previous quarter’s EPS was $1.43. CNMD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year CNMD has Performed in-line its overall industry.

CNMD Sales Forecast

Next quarter’s sales forecast for CNMD is $310.59M with a range of $309.70M to $311.21M. The previous quarter’s sales results were $373.47M. CNMD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CNMD has Performed in-line its overall industry.
Next quarter’s sales forecast for CNMD is $310.59M with a range of $309.70M to $311.21M. The previous quarter’s sales results were $373.47M. CNMD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year CNMD has Performed in-line its overall industry.

CNMD Stock Forecast FAQ

What is CNMD’s average 12-month price target, according to analysts?
Based on analyst ratings, Conmed’s 12-month average price target is 40.50.
    What is CNMD’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CNMD, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CNMD a Buy, Sell or Hold?
        Conmed has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Conmed’s price target?
          The average price target for Conmed is 40.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $42.00 ,the lowest forecast is $39.00. The average price target represents -8.68% Decrease from the current price of $44.35.
            What do analysts say about Conmed?
            Conmed’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.
              How can I buy shares of CNMD?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.